Sensai
Reading the tape…Pulling live market data…Setting the scene…
Sensai
AI Stock Dissection
AI Stock Dissection
STARHEALTH
Mr. Anand Shankar Roy · Chennai, India
₹598.85
▲+2.54%STAR Health shares are edging higher near their 52‑week high as earnings beat expectations and premium growth accelerates.
Exchange
NSI
Currency
INR
Day range
₹580.30 – ₹603.20
52-week range
₹416.55 – ₹623.90
Sector
Financial Services
Industry
Insurance - Life
AI investment rating
AI analysis78% confidence
The stock appears moderately overvalued on a 64× P/E versus peers, but strong earnings momentum and margin expansion justify its premium within the upper third of the 52‑week range.
4.0% below the 1-year high · trend up
Hedge-fund memo
Today
Up 1.93% to 610.4 INR, trading near the top of its 1‑year range.
This week
The stock has gained roughly 4% over the past five trading days, buoyed by better‑than‑expected Q4 results.
This month
Month‑to‑date, STAR Health is up about 7% as revenue growth of 13.8% YoY lifts earnings expectations.
Bull thesis
Bear thesis
Hidden risks
News & sentiment
Bullish
5 headlines · 2 outlets · 7d
Tone · daily average
Smart money
Named holders aren't published for this listing (common for Indian stocks). The split at left is live.
Financial health
Profitability
Growth
Balance sheet
Financial statements
Earnings intelligence
Beat estimates in 1 of 4 recent quarters (EPS actual vs. consensus).
1.89 vs 1.40725
34.30% surprise
2.18 vs 2.42202
-9.99% surprise
0.92 vs 1.90428
-51.69% surprise
Competitive landscape
| Company | Market cap | P/E | ROE | Op. margin | Rev. growth |
|---|---|---|---|---|---|
| STARHEALTH | 352.37B | 63.30 | — | 3.25% | 13.80% |
| POLICYBZR | 744.44B | 111.81 | 9.74% | 8.90% | 36.70% |
| METROBRAND | 281.45B | 68.47 | 22.09% |
Technical intelligence
Volume
RSI (14) · 70 overbought / 30 oversold
MACD (12,26,9) · MACD vs signal
Candlesticks, volume, RSI and MACD from 500sessions of real Yahoo daily data. Moving averages use full history, so they're accurate at the left edge. Support / resistance are the 52-week low / high. Educational — technical signals are not buy or sell calls.
Risk intelligence
Rising mortality or morbidity claims eroding margins
Mitigation: Focus on risk‑adjusted pricing and reinsurance protection.
Regulatory capital adequacy tightening
Mitigation: Maintain strong solvency ratio and diversify asset portfolio.
Business intelligence
Competitive moat
A strong brand combined with an extensive agent network and robust capital base creates a durable distribution advantage.
Supply chain
Upstream (inputs / suppliers)
↓
Downstream (customers / markets)
M&A / strategic moves
Catalyst calendar
Earnings release
Launch of AI‑driven underwriting platform
Thesis builder
Bull case
Sustained premium inflow and higher investment yields will lift EPS and justify a higher multiple.
Base case
Steady YoY revenue growth of ~14% and modest profit margin improvement keep earnings on an upward trajectory.
Bear case
If claim ratios rise or valuation compresses, the stock could retrace toward its 52‑week low.
Time horizon
12‑18 months
Est. CAGR
12%‑15% revenue CAGR over the next 3‑5 years
Entry (qual.)
Target entry near 590‑600 INR on pull‑back.
Exit (qual.)
Consider partial profit taking around 620‑630 INR or if P/E falls below 55x.
Overall conviction 78%
Knowledge graph
Executives & sector are live; peers are clickable → their dissection. Institutional holders shown where the exchange publishes them.
Portfolio impact
Enter tickers + weights, then see how STARHEALTH fits.
Scenario simulator
Simulate a macro shock and see the illustrative impact:
Tailwind for tech & enablers.
Illustrative impact
Medium prob.Directional illustration only — not modelled on this company's actuals. A real simulator needs company financials.
Explain like…
Re-explain STARHEALTH for a different audience:
Pick a persona to get a tailored explanation.
Sensai publishes educational market commentary, not investment advice. We are not SEBI-registered investment advisers or research analysts, and nothing here is a recommendation to buy, sell, or hold any security.
Live prices, index levels, and other market data are pulled from third-party feeds, may be delayed, and can be inaccurate or unavailable. Do not rely on them for trading decisions.
Investing in equities carries risk, including the loss of principal. Always do your own research and consider consulting a SEBI-registered adviser before making any investment decision.
Hidden opportunities
Watch next
Maintain a buy stance with a focus on entry near support around 590 INR and consider scaling out near 620 INR.
Content Media Solution·5h ago·large multi-year AI deal
TradingView·10h ago·GWP+19%, PAT+25%
TradingView·11h ago·GWP+19%, profit surge
TradingView·1d ago·Robust profit, board approvals
TradingView·3d ago·Revenue breakdown info
Real press coverage from the last 7 days, scored by AI for tone — click any headline for the source. This is news sentiment, not social: X / Reddit / Telegram scoring needs a paid social provider. Educational only.
Annual income statement, oldest → newest. Live via Yahoo.
4.42 vs 5.87125
-24.72% surprise
| 19.93% |
| 20.30% |
| NYKAA | 937.92B | 474.64 | 14.34% | 5.24% | 28.40% |
Peers via Yahoo's similarity graph, same-sector first; fundamentals live. Ask the AI copilot below for a qualitative head-to-head.
Support (day/52w low)
₹580.30
Resistance (day/52w high)
₹603.20
Volume
9,92,759
Trend
up
RSI (14)
48
MACD
bearish
MA cross
golden
50-day MA
₹560.53
200-day MA
₹496.13
vs 200-DMA
20.7%
RSI/MACD computed from 6 months of daily closes; moving averages from Yahoo. Options positioning still needs an options feed.